Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Outcomes of Protocol-Specified Modification of Immunosuppression Directed to Histological Diagnosis by Surveillance Protocol Biopsy

NCT02294097 is registered in ClinicalTrials.gov with Chulalongkorn University as lead sponsor.

NCT NCT02294097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02294097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Outcomes of Protocol-Specified Modification of Immunosuppression Directed to Histological Diagnosis by Surveillance Protocol Biopsy
Lead sponsor
Chulalongkorn University
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2014
Completion date
December 31, 2016
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

surveillance protocol biopsy